Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

“Downstream bottlenecks do occur in existing facilities producing very high-dose monoclonal antibodies for multiple indications. But based on our experience, for most products and indications, ...

Master of Biotechnology program (MBP) student Anita Huang looks back on her six-month internship at UCB in the United Kingdom and what she learned from the experience. In 2019, two students in ...

With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...

New manufacturing paradigm will save 25% of total costs and Specialist Process Innovation Group created to validate approach 12 February 2018, Wales:ADC Biotechnology (ADC Bio) announces that it is ...

Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the manufacturing of biological drugs. A recent publication ...

Standards organization says R2v3 certification entails accurately portraying operations of facilities receiving components and materials. SERI says qualifications for a non-R2v3 downstream vendor are ...

PERTH (miningweekly.com) – Diversified miner Independence Group has lodged a patent application for a new process to produce high quality nickel sulphate from nickel sulphide concentrate. The company ...

Research led by Duke University, Durham, has discovered a situation-dependent traffic jam in mRNA translation caused by RNA hairpins leading to higher translation of upstream start codons (uAUGs). In ...